Intravenous Thrombolysis and NOAC

PHASE3RecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Intravenous thrombolysis

Patients will receive standard dose intravenous alteplase (0.9 mg/kg, the first 10% administered as an initial bolus and the remainder over a 1-hour period, with a maximum dose of 90 mg),intravenous Tenecteplase(0.25mg/kg,administered as a single intravenous bolus injection over 5 - 10 seconds,with a maximum dose of 25 mg), intravenous reteplase (a bolus of 18 mg followed by a second bolus of 18 mg after 30 minutes) and intravenous prourokinase (rhPro-UK) (15 mg bolus followed by a 20 mg infusion over 30 minutes).

Trial Locations (2)

310000

NOT_YET_RECRUITING

Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Hangzhou

317500

RECRUITING

The First People's Hospital of Wenling, Taizhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER